Navigation Links
FDA: Risk of Oral Birth Defects in Children Born to Mothers Taking Topiramate
Date:3/4/2011

t prevalence of oral clefts, compared with a prevalence of 0.38 percent – 0.55 percent in infants exposed to other antiepileptic drugs.

Infants of mothers who did not have epilepsy and were not being treated with other antiepileptic drugs had a prevalence of 0.07 percent. Similar data from the United Kingdom Epilepsy and Pregnancy Register supported the North American AED Pregnancy Registry data.

Based on the data, topiramate will have a stronger warning in its prescribing information (labeling). The pregnancy category will be changed to Pregnancy Category D. This means that there is positive evidence of human fetal risk based on human data, but the potential benefits of the drug in pregnant women may outweigh the risks in certain situations. The FDA previously designated the drug as Pregnancy Category C because of the lack of human data. More information about the Pregnancy Categories can be found in the FDA's Drug Safety Communication: http://www.fda.gov/Drugs/DrugSafety/ucm245085.htm

The patient medication guide and prescribing information for Topamax and generic topiramate will be updated with the new information.

Before starting topiramate, pregnant women and women of childbearing potential should discuss other treatment options with their health care professional. Women taking topiramate should tell their health care professional immediately if they are planning to or become pregnant. Patients taking topiramate should not stop taking it unless told to do so by their health care professional.  

Women who become pregnant while taking topiramate should talk to their health care professional about registering with the North American Antiepileptic Drug Pregnancy Registry (http://www2.massgeneral.org/aed/), a group that collects information about outcomes in infants born to women treated with antiepileptic dru
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
2. Male Birth Control Pill, Blackberry Extract for Gingivitis, Skin Cancer and Digestive Health Top List of New Medical Discoveries
3. Huge Drop in Preterm Birth-Risk Among Women Taking Folic Acid One Year Before Conception
4. Molecular Therapy Succeeds in Preventing Craniofacial Birth Defect in Mice
5. National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births
6. Infant Blood May Provide Insights into Diseases Present at Birth
7. Preterm Births Rise 36 Percent Since Early 1980s
8. New Study Proves Multiple Births From IVF Can Be Avoided
9. Taking Folic Acid for a Year Before Pregnancy May Reduce Risk of Preterm Birth
10. Diabetes Gene Raises Odds of Lower Birth Weight
11. Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... BRANFORD, Conn. , May 23, 2013  CAS Medical ... in medical devices for non-invasive patient monitoring, today announced that ... Executive Officer,  will present at the 2 nd Annual ... Grand Hyatt Hotel in New York City ... 1:30 p.m. ET in the Estate 10 room and will ...
(Date:5/23/2013)... NEW YORK , May 23, 2013  Intercept ... clinical stage biopharmaceutical company focused on the development and ... liver diseases, such as primary biliary cirrhosis, today announced ... and Chief Executive Officer, will present at the Deutsche ... Boston on Wednesday, May 29, 2013 ...
(Date:5/23/2013)... Calif. , May 23, 2013 Isis Pharmaceuticals, ... therapeutics, today announced that management will present a company overview ... Care Conference on Thursday, May 30, 2013 at 8:40 a.m. ... A live audio webcast of the presentation will be available ... site, www.isispharm.com .  A replay will be available on ...
Breaking Medicine Technology:CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2
... Anthera Pharmaceuticals,Inc., a privately-held biopharmaceutical company, ... of its first compound, A-002, for the ... that treatment with A-002,resulted in significant reductions ... Density Lipoprotein Cholesterol (non HDL-C), and Low ...
... Trial Reaffirms Primacy and Safety of ,First Generation, ... Genta,Incorporated (Nasdaq: GNTA ) announced the presentation ... its lead anticancer,compound, can be safely administered in ... new data were presented by Dr. Anthony Tolcher, ...
Cached Medicine Technology:Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial 2Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial 3Genasense(R) Can be Administered by Brief High-Dose IV Infusion 2Genasense(R) Can be Administered by Brief High-Dose IV Infusion 3Genasense(R) Can be Administered by Brief High-Dose IV Infusion 4
(Date:5/23/2013)... arch pulse wave velocity, a measure of arterial stiffness, ... vessels that supply blood to the brain, according to ... journal Radiology . , "Pulse wave velocity ... compliance that may help determine a patient,s risk for ... M.D., assistant professor of radiology at UT Southwestern Medical ...
(Date:5/23/2013)... 23, 2013 Applied PilotFish Healthcare ... that it has added support for the Direct Protocol ... eiConsole for Healthcare. In addition to the product’s already ... FTP, and Web Services, it now offers support for ... is a specification of the Direct Project ...
(Date:5/23/2013)... Elegance for a woman takes on so many different ... intrigue can often be found in the mystery of her eyes. ... is through her eyes. It is also true that that ... why the elegance of a woman can be found in her ... than any other time, utilize eyewear to not only compliment but ...
(Date:5/23/2013)... May 23, 2013 Aero Fulfillment Services, ... selected by NewWave Biosciences to be the sole fulfillment ... care professionals. , Brad Cole, CEO New Wave ... reasons including their central location, e-commerce experience with both ... and overall end-to-end solution that will expand as our ...
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 Each month ... most innovative and stylish eco-friendly hybrids and electric cars. Nowhere ... in Los Angeles, the symbolic green car capital. Thankfully this ... Car Tour ride and drive back to Dwell on ... event. , During the first two days of Dwell ...
Breaking Medicine News(10 mins):Health News:MRI-based measurement helps predict vascular disease in the brain 2Health News:PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release 2Health News:Dolabany Eyewear Adds Feminine Flare to Women's Designer Eyewear with 2013 New Release of Adelina by Best Image Optical, Inc. 2Health News:NewWave Biosciences Chooses Aero Fulfillment for e-Commerce Distribution of New Product to Reduce Inflammation 2Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 2Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 3Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 4Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 5
... ST-elevation myocardial infarction (STEMI) guidelines, protocols and standing ... labs has dramatically improved since 2003, according to ... the American College of Cardiology (ACC) Scientific Sessions ... Since the 1990s, the American College Cardiology (ACC)/American ...
... at the Queen Silvia Children,s Hospital has developed a method ... having a CT scan while still obtaining good image quality, ... is an advanced form of X-ray examination which generates images ... If the dose of radiation is lowered too far, however, ...
... Steven Reinberg HealthDay Reporter , MONDAY, April 4 ... failure because of blocked coronary arteries appear to fare as ... surgery or rely on medication alone, a new study seems ... found that bypass surgery does reduce the risk ...
... , MONDAY, April 4 (HealthDay News) -- People ... a new study suggests. It also found that a ... substance abuse and mood disorders. Researchers analyzed data from ... in the U.S. National Epidemiologic Survey of Alcohol and Related ...
... Alan Mozes HealthDay Reporter , MONDAY, April 4 ... a connection between listening to pop music and suffering from ... from your child,s MP3 player, know that the study did ... indication whether kids who were predisposed to depression were more ...
... in collaboration with researchers from Stony Brook University, has ... by 63 per cent. Shor reached these conclusions by ... (mainly western) countries, over the last 40 years. ... expectations that a better health-care system might contribute to ...
Cached Medicine News:Health News:Protocol-driven heart attack care proves effective and contagious 2Health News:Safer CT scanning for children developed at the Queen Silvia Children's Hospital 2Health News:Bypass Surgery Best for Some Heart Failure Patients 2Health News:Bypass Surgery Best for Some Heart Failure Patients 3Health News:Poverty Linked to Anxiety, Mood Disorders 2Health News:Could Pop Music Be Linked to Depression? 2Health News:Could Pop Music Be Linked to Depression? 3Health News:Men who lose their jobs at greater risk of dying prematurely 2
... IgG Test is an ELISA method for the ... viral capsid antigen (VCA) in human serum. When ... with other testing such as the EBV nuclear ... tests and/or heterophile tests, the results can serve ...
... (Lyme) test is an enzyme ... the qualitative detection of borrelia ... related Borrelia burgdorferi antibodies (IgG, ... in serum as an aid ...
The ImmunoWELL Borrelia (Lyme) Test is an enzyme immunoassay (EIA) for the qualitative and/or semiquantitative detection of Borrelia burgdorferi total antibodies (IgG, IgM, and IgA) in serum and is u...
The ImmunoWELL Thyroglobulin IgG Quantitative Test is a quantitative enzyme immunoassay (EIA) for screening and detection of autoantibodies against human thyroglobulin in serum and is used as an aid ...
Medicine Products: